Previous 10 | Next 10 |
Gainers: Biofrontera (NASDAQ: BFRA ) +75% . More news on: Biofrontera AG, Pfenex Inc., Oxbridge Re Holdings Limited, Stocks on the move, , Read more ...
DOYLESTOWN, Pennsylvania, Aug. 11, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced net sales of $3.6 million for the three months ended June 30, 2020, compared to net sales of $1.7 million for the three months ended June 30, 2019. The Compan...
DOYLESTOWN, Pennsylvania, May 12, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com ) today announced net sales of $1.9 million for the three months ended March 31, 2020, compared to net sales of $2.3 million for the three months ended March 31, 2019. The...
DOYLESTOWN, Pennsylvania, March 25, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com ) today announced its net sales were $9.9 million for the year ended December 31, 2019, as compared to net sales of $13.1 million for the year ended December 31, 2018. Th...
ProPhase Labs (NASDAQ: PRPH ) declares $0.25/share special dividend . Payable Dec. 12; for shareholders of record Dec. 3; ex-div Dec. 2. See PRPH Dividend Scorecard, Yield Chart, & Dividend Growth. More news on: ProPhase Labs, Inc., Dividend News, ,
ProPhase Labs (NASDAQ: PRPH ): Q3 GAAP EPS of -$0.04. More news on: ProPhase Labs, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
DOYLESTOWN, Pennsylvania, Nov. 12, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.8 million for the three months ended September 30, 2019 compared to net sales of $2.4 million for the three months ended September 30, 2018...
DOYLESTOWN, Pa., Aug. 12, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com ) today reported net sales of $1.7 million for the three months ended June 30, 2019 compared to net sales of $3.2 million for the three months ended June 30, 2018. The Company incu...
ProPhase Labs (NASDAQ: PRPH ): Q1 GAAP EPS of -$0.09. More news on: ProPhase Labs, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
DOYLESTOWN, Pa., May 14, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.3 million for the three months ended March 31, 2019, compared to net sales of $3.4 million for the three months ended March 31, 2018. The Company incu...
News, Short Squeeze, Breakout and More Instantly...
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results...
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm ES...
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company...